August 15th 2025, 8:00pm
It is important to expand clinical trial access for patients with kidney cancer in order to ensure a representative study population.
August 15th 2025, 7:00pm
Intensive chemotherapy improved survival in patients with accelerated and blast phase myeloproliferative neoplasms, with Venclexta showing no clear benefit.
August 15th 2025, 5:00pm
A diagnosis of breast cancer isn’t something most people would think of as a teacher, but sometimes important lessons come to us in unexpected ways.
August 15th 2025, 4:00pm
Cancer treatments can speed up aging in survivors, according to research, which can contribute to a person's risk for conditions like heart disease.
August 15th 2025, 3:00pm
The FDA has granted fast track designation to HLD-0915 for metastatic castration-resistant prostate cancer.
August 15th 2025, 1:00pm
The accelerated approval of Modeyso for diffuse midline glioma with an H3 K27M mutation, is a step in the right direction but more work remains.
August 14th 2025, 9:00pm
Breast cancer survivor and researcher LaShae Rolle studies how individualized strength training during chemo boosts physical, mental and emotional health.
August 14th 2025, 8:00pm
Dr. Jim Omel, who was diagnosed with multiple myeloma in 1997, explained how the treatment landscape has changed over nearly 30 years.
August 14th 2025, 7:00pm
More than half of patients with myelofibrosis and low platelets treated with Vonjo saw platelets rise 58% and hemoglobin levels improve.
August 14th 2025, 5:00pm
Living with stage 4 cancer taught me the power of community; connecting with others provides guidance, support, and hope in an often-lonely journey.
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC